RT Journal Article
SR Electronic
T1 Evolution of COVID-19 Pandemic in India
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.01.20143925
DO 10.1101/2020.07.01.20143925
A1 Asad, Ali
A1 Srivastava, Siddharth
A1 Verma, Mahendra K.
YR 2020
UL http://medrxiv.org/content/early/2020/07/02/2020.07.01.20143925.abstract
AB A mathematical analysis of patterns for the evolution of COVID-19 cases is key to the development of reliable and robust predictive models potentially leading to efficient and effective governance against COVID-19. Towards this objective, we study and analyze the temporal growth pattern of COVID-19 infection and death counts in various states of India. Our analysis up to June 16, 2020 shows that several states (namely Maharashtra, Tamil Nadu, Delhi, Uttar Pradesh) have reached t2 power-law growth, while some others like Gujarat, Rajasthan, and Madhya Pradesh have reached linear growth. Karnataka and Kerala are exhibiting a second wave. In addition, we report that the death counts exhibit similar behaviour as the infection counts. These observations indicate that Indian states are far from flattening their epidemic curves.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAli Asad is supported by Indo-French (CEFIPRA) project 6104-1.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not Required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used is available online